LO2A

DRUG2 trials

Sponsors

Ocuwize LTD

Conditions

Conjunctivochalasis

Phase 2

Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis

CompletedNCT02804191

Ocuwize LTDConjunctivochalasis

Start: 2016-07-31End: 2019-06-30Updated: 2021-02-25

To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis

CompletedNCT02810119

Ocuwize LTDConjunctivochalasis

Start: 2016-11-30End: 2017-10-31Updated: 2017-10-27